期刊文献+

阿格列汀联合二甲双胍治疗肥胖2型糖尿病40例效果观察

The Effect of Alogliptin Combined with Metformin on Glucose and Lipid Metabolism and Stress Response in Obese Patients with Type 2 Diabetes
下载PDF
导出
摘要 目的:探讨阿格列汀联合二甲双胍对肥胖2型糖尿病患者糖脂代谢及应激反应的影响。方法:选取2017年9月至2020年9月赣南医学院第三附属医院收治的80例肥胖2型糖尿病患者分为A组和B组,分组方式为随机数字表法,各40例。A组给予盐酸二甲双胍缓释片,B组在此基础上加用苯甲酸阿格列汀片,两组均治疗15周。比较两组治疗前后的血糖血脂水平、胰岛功能变化、氧化应激相关因子水平以及治疗期间的不良反应发生情况。结果:治疗后两组患者血清TG、TC、MDA、FPG、2 h FPG水平均降低,且B组低于A组;治疗后两组患者血清FINS、2 h INS、C-P、2 h C-P、GSH-PX、SOD水平均升高,且B组血清FINS、2 h INS、C-P、2 h C-P、GSH-PX、SOD水平均高于A组(P<0.05);治疗期间,B组患者不良反应总发生率为5.00%,A组15.00%,两组差异无统计学意义(P>0.05)。结论:阿格列汀联合二甲双胍可更明显降低肥胖2型糖尿病患者的血糖和血脂水平,在一定程度上提升患者胰岛功能,减轻氧化应激反应对患者机体的损伤,且安全性较好。 Objective:To investigate the effect of alogliptin combined with metformin on glucose and lipid metabolism and stress response in obese type 2 diabetic patients.Methods:A total of 80 obese type 2 diabetic patients admitted to The Third Affiliated Hospital of Gannan Medical College from September 2017 to September 2020 were divided into group A and group B.The grouping method was random number table method,with 40 cases in each group.Group A was given metformin hydrochloride sustained-release tablets,and group B was given alogliptin benzoate tablets on this basis.Both groups were treated for 15 weeks.The blood glucose and blood lipid levels,changes in islet function,levels of oxidative stress-related factors and adverse reactions during the treatment period were compared between the two groups before and after treatment.Results:After treatment,the serum TG,TC,MDA,FPG,2 h FPG levels of the two groups of patients decreased,and the B group was lower than the A group;after the treatment,the serum FINS,2 h INS,C-P,2 h C-P,GSH-PX,SOD levels of the two groups of patients increased.The levels of serum FINS,2 h INS,C-P,2 h C-P,GSH-PX and SOD in group B were all higher than those in group A(P<0.05);during the treatment period,The total incidence of adverse reactions in group B was 5.00%,which was lower than 15.00%in group A,but there was no significant difference(P>0.05).Conclusion:Alogliptin combined with metformin can significantly reduce the blood glucose and blood lipid levels of obese type 2 diabetic patients,improve the pancreatic islet function in patients to a certain extent,reduce the damage of oxidative stress to the patient's body,and have better safety.
作者 张微 ZHANG Wei(The Third Affiliated Hospital of Gannan Medical College,Ganzhou Jiangxi 341000,China)
出处 《药品评价》 CAS 2021年第20期1263-1266,共4页 Drug Evaluation
关键词 2型糖尿病 肥胖 二甲双胍 阿格列汀 糖脂代谢 氧化应激 不良反应 Type 2 diabetes Obesity Metformin Alogliptin Glucose and lipid metabolism Oxidative stress Adverse reactions
  • 相关文献

参考文献8

二级参考文献67

共引文献686

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部